Table 1.
Clinical characteristics of the clinical DCE-MRI dataset.
| Benign/malignant prevalence: no. cases (%) | Benign | 212 (30.7) |
| Malignant | 478 (69.3) | |
| Age: mean (STD) |
54.9 (13.3) Unidentified cases: 103 |
|
| Benign tumor characteristics | ||
| Tumor subtypes: | Fibroadenoma | 87 |
| Fibrocystic change | 77 | |
| Papilloma | 12 | |
| |
Unidentified |
36 |
| Malignant tumor characteristics | ||
| Tumor subtypes: | Invasive ductal carcinoma | 135 |
| Ductal carcinoma in situ | 19 | |
| Invasive ductal carcinoma + ductal carcinoma in situ | 263 | |
| Invasive lobular carcinoma | 18 | |
| Invasive lobular carcinoma mixed | 19 | |
| Unidentified | 24 | |
| Estrogen receptor status: no. of cases | Positive | 328 |
| Negative | 108 | |
| Unidentified | 42 | |
| Progesterone receptor status: no. of cases | Positive | 274 |
| Negative | 159 | |
| Unidentified | 45 | |
| HER2 status: no. of cases | Positive | 72 |
| Negative | 349 | |
| Equivocal | 3 | |
| Unidentified | 54 | |